Study to Evaluate the Pharmacodynamic Effects of a Single Oral Dose of GS-0976 (NDI-010976) in Healthy Adult Subjects

NCT02876796 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

PD Effects of GS-0976 (NDI-010976) on Fractional DNL

Interventions

DRUG: GS-0976
DRUG: Placebo
OTHER: 1-13C acetate
OTHER: Fructose solution

Sponsor

Gilead Sciences

Collaborators

[object Object]